Ocugen and Bharat Biotech have entered into an amendment to their Co-development, Supply, and Commercialization Agreement to expand Ocugen’s exclusive…
Since March, over 400 US colleges and universities have announced students get Covid-19 vaccinations, ahead of the Autumn semester but…
Maharashtra state-owned Haffkine Biopharma on June 2 said it plans to produce 22.8 crore (228 million) doses of Covaxin in…
The Union Health Ministry today once again reiterated that there is absolutely no change in the schedule of Covishield doses…
he central government will support Hyderabad based Indian Immunological limited (IIL) with grants under the Mission COVID Suraksha for developing…
Manufacturing to supply of Covid-19 vaccine Covaxin involves four months of lag time depending on technology and regulatory approvals, Bharat…
In the first of its kind study since the launch of the AstraZeneca's Covishield and Bharat Biotech's Covaxin in the…
The World Health Organisation (WHO) has said more information is required from Bharat Biotech, which is seeking emergency use listing…
Bharat Biotech, the maker of coronavirus disease vaccine Covaxin, is expected to start paediatric trials from June, the company's Business…
Few side effects of vaccination are common and that shouldn’t deter anyone from taking it said Dr. Raches Ella, Head-Business…